Trontinemab trials for Alzheimer's disease

All Trontinemab trials · All Alzheimer's disease trials

Phase breakdown

Recruiting trials studying Trontinemab for Alzheimer's disease

• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
  NCT07170150 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · 150 locations
• A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
  NCT07717411 · Phase: Phase 3 · Ages: 55 Years to 80 Years · Sex: All (male and female) · 7 locations
• A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
  NCT07169578 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · 143 locations

Common questions

How many trials study Trontinemab for Alzheimer's disease?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.